Saltar al contenido
Salud mental y cogniciónEnsayo aleatorizado3 min read

Home walking during chemo improved self-rated thinking, not tested cognition

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. · PloS one · 2018 · Artículo original ↗

Idea principal

In a small trial of 50 women having chemotherapy for breast cancer, 12 weeks of home-based moderate walking improved perceived cognitive function versus usual care, but not attention, executive function, memory or visuospatial skills on objective tests. The abstract gives no numbers for the effect, and the sample is small.

Study design

Ensayo aleatorizado

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Many people treated with chemotherapy for breast cancer notice, and tests can detect, problems with thinking and concentration. Walking has helped cognition in other groups, so the authors tested whether a self-managed moderate walking programme could protect thinking in this setting.

Población y método

Randomised controlled trial of 50 breast cancer patients, randomised mid-way through chemotherapy to a home-based, self-managed programme of 12 weeks of moderate-intensity walking (n = 25) or usual care (n = 25). Perceived cognition was measured with the Cognitive Failures Questionnaire (CFQ); objective cognition with the Stroop test, Sustained Attention to Response Task (SART), and the Digit Span and Block Design subscales of the WAIS. The abstract does not report scores, effect sizes or walking adherence.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Compared with usual care, the walking group showed positive effects on perceived (self-rated) cognitive function.
  2. 2
    No benefit was found on sustained attention, executive function, memory or visuospatial skills when measured with neuropsychological tests.
  3. 3
    The abstract reports no effect sizes, confidence intervals or P values for either result, so the size of the self-rated benefit cannot be judged.

Límites e incertidumbre

  1. 1
    With 25 women per group the trial is small, and the authors themselves call for larger samples to assess cognition objectively.
  2. 2
    Self-rated cognition cannot be hidden from participants who know they are walking, so expectation may have shaped the positive result.
  3. 3
    The mismatch between self-rated and objective results means the walking may have changed how people felt about their thinking more than how they performed.
  4. 4
    This reading is based on the abstract only, which gives no numbers.

Relevancia práctica

Walking during chemotherapy may help you feel your thinking is sharper, but this small trial did not show better performance on cognitive tests. Anyone having chemotherapy should check with their oncology team before starting an exercise plan.

Tus datos

If your care team approves, daily steps or walking minutes from a wearable are an easy way to keep a regular walking routine. Compare weekly averages on the same device, and note how you feel alongside the numbers, since the study found a perceived rather than a measured benefit.

Cómo interpretar la evidencia

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Cancer related cognitive impairments have been subjectively reported and objectively detected in breast cancer patients treated with chemotherapy and are known to have a profound negative impact on productivity, psychosocial well-being and overall quality of life. Moderate levels of walking are known to be of benefit to the psychosocial well-being of those affected by breast cancer and for managing cognitive impairment in healthy adults, children, and the elderly. The purpose of this study is to investigate the effects of a home-based, self-managed, moderate intensity walking intervention on subjective and objective cognitive functioning in breast cancer patients undergoing chemotherapy.

Methods

A home-based, self-managed intervention that consisted of moderate levels of walking was compared to usual care among breast cancer patients treated with chemotherapy in a randomised controlled trial. Outcome measures included changes in subjective (CFQ) and objectively detected cognitive functioning (Stroop, SART and two subscales from the WAIS- Digit Span and Block Design). Fifty participants were randomised to either the intervention group (n = 25), who completed 12 weeks of moderate intensity walking, or to the control group (n = 25) mid-way through chemotherapy.

Results

Compared with the control group, the self-managed walking intervention had positive effects on perceived cognitive function but not on sustained attention, executive function, memory or visual spatial skills when assessed objectively using neuropsychological measures.

Conclusion

This home-based, self-managed intervention is beneficial for protecting against perceived cognitive decline in breast cancer patients treated with chemotherapy. There is a need for further research to objectively assess cognitive decline within this population with larger sample sizes of patients.

Trial registration

Current Controlled Trials ISRCTN50709297.

Fuentes y atribución

Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.

Gokal K, Munir F, Ahmed S, Kancherla K, Wallis D.

PloS one · 2018-11-28

DOI: 10.1371/journal.pone.0206874 ↗PubMed · 30485297 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Revisión de revisiones

Exercise gave small-to-moderate cognitive gains across 133 reviews of trials

An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

More daily steps linked to fewer depressive symptoms across 33 studies of adults

Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.

JAMA Network Open

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Exercise eased depression in 218 trials, but confidence in the evidence is low

In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.

BMJ

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Physical activity eased depression and anxiety across 97 reviews of trials

Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
Salud mental y cognición →